Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3014959	s-toxoab	— (—)	5151	6567	100.00%	Distribution not available
3014959	s-toxoabg	— (—)	4567	5703	100.00%	Distribution not available
3014959	s-toxoabg	iu/ml (—)	498	567	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Myeloid leukaemia

191

45.19

314.28

2.8

2.4

—

Other bacterial diseases

1311

2589

3.56

307.65

2.5

2.4

—

Glomerular disorders in diseases classified elsewhere

495

366

15.02

307.65

2.3

2.4

—

ILD medications: prednisolone, methylprednisolone, prednisone

1768

2812

3.62

307.65

2.4

2.5

—

Kidney transplant status

847

180

83.11

307.65

2.3

2.5

—

Chronic kidney disease

1052

550

20.60

307.65

2.3

—

Septicaemia

626

1037

5.96

307.65

2.5

2.4

—

Secondary hypertension

444

179

27.97

307.65

2.3

2.7

—

Deposits [accretions] on teeth

310

222

14.96

307.65

2.6

2.4

—

Care involving dialysis

824

195

57.42

307.65

2.3

2.4

—

Primary_lymphoid and hematopoietic malignant neoplasms

747

558

14.35

307.65

2.7

2.3

—

Disorders resulting from impaired renal tubular function

267

35.51

307.65

2.3

2.4

—

Dialysis

446

102

62.08

307.65

2.3

2.4

—

Dentinal caries

648

827

8.22

307.65

2.4

2.5

—

First line medication for Crohn's disease

1737

2923

3.29

307.65

2.4

2.5

—

Extracorporeal dialysis

577

190

40.86

307.65

2.3

2.4

—

Bacterial infection, other or unspecified

862

1331

6.00

307.65

2.5

2.4

—

Heart failure, not strict

1284

1460

6.23

307.65

2.3

2.4

—

Nephropathy related operations

1137

314

47.00

307.65

2.3

2.4

—

Renal failure

1195

847

13.63

307.65

2.3

2.4

—

Other septicaemia

581

931

6.30

307.65

2.5

2.4

—

Acute renal failure

413

407

10.61

307.65

2.4

—

Renal tubulo-interstitial diseases

1436

2905

3.87

307.65

2.3

2.5

—

Other dialysis

344

53.82

307.65

2.3

2.4

—

ILD medications: immunosuppressive drugs

1652

2201

7.51

307.65

2.4

2.5

—

L04AA Selective immunosuppressants

1046

753

15.47

307.65

2.3

2.5

—

Preparatory care for dialysis

399

114

47.43

307.65

2.2

2.4

—

Donors of organs and tissues

209

80.56

307.65

3.2

2.5

—

Transplanted organ and tissue status

1437

226

100.66

307.65

2.6

2.3

—

Dialysis, with operation codes

1122

311

45.92

307.65

2.3

2.4

—

Chronic periapical parodontitis

483

619

8.17

307.65

2.4

—

Glomerular diseases

650

605

11.64

307.65

2.3

2.5

—

Persons encountering health services for specific procedures and health care

1732

3126

3.49

307.65

2.4

2.5

—

Failure and rejection of transplanted organs and tissues

188

82.61

307.65

2.9

2.3

—

L04AD Calcineurin inhibitors

1204

333

50.02

307.65

2.4

—

Dental caries

755

959

8.22

307.65

2.4

2.5

—

Fever of other and unknown origin

985

2010

4.66

307.65

2.5

—

Chronic periodontitis

420

362

12.36

307.65

2.4

—

Primary_lymphoid and hematopoietic malignant neoplasms

747

553

14.48

307.65

2.7

2.3

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

1877

2637

4.96

307.65

2.5

2.4

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

1472

3020

3.56

307.65

2.4

2.5

—

ILD medications

1899

2895

3.67

307.65

2.4

2.5

—

Explicit Sepsis

663

1299

5.02

298.80

2.6

2.5

—

Myeloid leukaemia

191

36.24

294.68

2.8

2.4

—

Enlarged lymph nodes

407

530

8.06

294.51

2.3

2.6

—

Other disorders of kidney and ureter

331

357

9.86

279.32

2.3

2.4

—

Aplastic and other anaemias

608

1157

5.10

278.60

2.4

—

Cystic kidney disease

209

115

21.84

268.23

2.2

2.4

—

Diseases of pulp and periapical tissues

613

1303

4.83

267.68

2.4

—

Direct fill therapy

398

579

7.31

261.83

2.4

—

Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)

273

248

11.54

259.52

2.5

2.4

—

Other/unspecified cytomegaloviral diseases

166

32.95

244.42

2.4

2.3

—

Cytomegalovirus infection, IBD co-morbidity

174

28.10

244.04

2.4

2.3

—

Implicit bacterial Sepsis

500

862

5.44

243.55

2.5

2.3

—

Bacterial Sepsis

570

1064

4.86

242.59

2.5

2.4

—

Acute myeloid leukaemia and myelodysplastic syndromes, excluding all cancers (controls excluding all cancers)

159

32.74

242.56

2.7

2.4

—

Unspecified kidney failure

213

148

15.17

238.60

2.2

2.3

—

Cytomegaloviral disease

175

25.94

238.49

2.4

—

Glomerulonephritis

301

368

8.75

230.67

2.3

2.4

—

Hypertensive diseases (excluding secondary)

822

1258

3.87

225.68

2.3

2.6

—

Congenital malformations of the urinary system

251

258

10.81

221.36

2.3

2.4

—

Anaemias

588

852

4.74

215.88

2.5

2.6

—

Viral Sepsis

343

536

6.63

209.66

2.4

—

Implicit viral Sepsis

341

535

6.60

207.63

2.4

—

Diabetic nephropathy

330

498

6.88

205.73

2.3

2.4

—

Hypertensive diseases

1004

1838

3.13

202.39

2.3

2.5

—

Hypertension

1003

1835

3.14

202.30

2.3

2.5

—

Chronic periodontitis, complicated

248

282

9.37

201.21

2.4

—

Heart failure and antihypertensive medication

412

449

6.23

199.75

2.3

2.6

—

Any gastric operation

1122

1914

2.98

199.69

2.5

2.6

—

GASTRO-related operations

1122

1914

2.98

199.69

2.5

2.6

—

Implicit Sepsis

838

2077

3.18

191.34

2.4

2.5

—

Diabetic nephropathy, excluding more controls

326

416

6.88

189.64

2.3

2.4

—

General symptoms and signs

1425

2860

2.53

188.34

2.4

2.5

—

Other and unspecified anaemias

471

1034

4.49

187.35

2.5

2.4

—

Other disorders involving the immune mechanism, not elsewhere classified

168

123

15.85

185.47

2.2

2.5

—

Other anaemias

473

1050

4.43

184.72

2.5

2.4

—

Infections, IBD-co-morbidities

363

438

6.24

183.91

2.5

—

Other diseases of blood and blood-forming organs, wide

377

732

5.32

183.56

2.5

2.4

—

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

163

116

16.44

183.04

2.2

2.5

—

Non-follicular lymphoma, hilmo, excluding all cancers

191

175

11.47

180.68

2.6

2.4

—

IgA nephropathy (IgA glomerulonephritis)

147

18.85

176.16

2.1

2.5

—

Acute myeloid leukaemia and myelodysplastic syndromes

109

38.39

172.57

2.7

2.5

—

Acute peritonitis

190

186

10.99

172.50

2.3

2.5

—

Chronic nephritic syndrome

159

120

14.71

171.36

2.2

2.5

—

Lymphoid leukaemia

158

119

14.31

169.66

2.3

2.5

—

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

159

122

13.69

168.22

3.3

2.3

—

Anaemia in chronic diseases classified elsewhere

121

25.08

166.53

2.3

—

Certain infectious and parasitic diseases

1207

2405

2.54

161.62

2.5

—

Lung transplant status

100

51.42

161.62

2.3

2.4

—

Lung transplantation

100

51.28

161.58

2.3

2.4

—

Multiple myeloma, excluding all cancers (controls excluding all cancers)

125

20.40

161.10

3.5

2.3

—

Hyperparathyroidism

263

405

6.60

160.31

2.2

2.3

—

Disorders of parathyroid gland

284

482

5.98

156.81

2.2

2.4

—

Multiple myeloma and malignant plasma cell neoplasms

123

19.76

156.27

3.5

2.3

—

Heart failure,strict

476

839

4.15

156.11

2.3

2.4

—

Condition for Implicit Sepsis (Organ dysfunction codes)

929

2537

2.69

155.43

2.4

2.5

—

Non-follicular lymphoma

191

219

9.15

153.56

2.6

2.3

—

Acute myeloid leukaemia, helper endpoint

58.39

152.55

2.8

2.6

—

Acute myeloid leukaemia, excluding all cancers (controls excluding all cancers)

58.39

152.55

2.8

2.6

—

Chronic lymphocytic leukaemia, helper endpoint

33.30

152.32

2.2

—

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)

33.30

152.32

2.2

—

ILD medications: azathioprine

287

526

5.65

149.14

2.4

2.5

—

Lymphoid leukaemia

158

148

11.49

147.89

2.3

2.5

—

Certain disorders involving the immune mechanism

335

712

4.86

146.91

2.3

2.5

—

Acute myeloid leukaemia

44.84

142.81

2.8

2.7

—

Other heart diseases

646

1373

3.15

138.71

2.4

2.6

—

Gout, FINNGEN

304

647

4.79

132.53

2.3

—

Other diseases of hard tissues of teeth

776

2169

2.70

131.69

2.5

2.4

—

Leukaemia of unspecified cell type

76.97

130.15

2.6

2.5

—

Other disorders of teeth and supporting structures

306

667

4.70

129.85

2.3

2.4

—

Nephrotic syndrome

131

114

12.83

129.56

2.4

2.5

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

342

787

4.36

129.24

2.4

2.5

—

Multiple myeloma and malignant plasma cell neoplasms

123

13.62

128.50

3.5

2.3

—

Cirrhosis of liver, NAS

129

112

12.35

126.92

2.3

2.4

—

Fibrosis and cirrhosis of liver

160

189

8.93

125.83

2.4

—

Chronic lymphocytic leukaemia

19.93

125.09

2.2

—

Agranulocytosis

212

349

6.33

123.53

2.7

2.4

—

Hypertension, essential

798

1721

2.67

123.29

2.3

2.6

—

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

230

411

5.79

122.89

2.4

2.3

—

Diseases of peritoneum

203

325

6.52

121.65

2.3

2.4

—

Cardiovascular diseases (excluding rheumatic etc)

970

2377

2.39

119.34

2.4

2.6

—

Missing teeth due to accident, extraction or parodontitis

189

289

6.77

118.17

2.3

2.4

—

Oesophageal varices

123

113

11.80

116.84

2.3

2.4

—

Secondary and unspecified malignant neoplasm of lymph nodes

171

241

7.44

115.68

2.5

2.4

—

Leukaemia of unspecified cell type

41.84

113.34

2.6

2.5

—

Covid-19 confirmed case

413

1239

3.41

112.11

2.4

2.5

—

Azathioprine

287

672

4.41

111.67

2.4

2.5

—

Factors influencing health status and contact with health services

295

276

5.41

111.22

2.4

2.2

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1226

3369

2.09

110.91

2.5

—

Metabolic disorders

952

2604

2.29

109.77

2.4

2.5

—

Gout

304

670

4.21

109.69

2.3

—

Other viral diseases

491

1682

2.98

106.03

2.5

—

Secondary and unspecified malignant neoplasm of lymph nodes, excluding all cancers (controls excluding all cancers)

194

340

5.86

105.66

2.5

2.4

—

Genitourinary diseases

792

1591

2.52

105.04

2.5

—

Influenza and pneumonia

1182

3824

2.05

105.02

2.5

—

General examination and investigation of persons without complaint and reported diagnosis

761

1611

2.54

104.36

2.5

2.4

—

Secondary uncertain malignant neoplasm

189

329

5.93

103.80

2.5

2.4

—

Pneumonias (Asthma/COPD co-morbidities)

1085

3617

2.10

103.51

2.4

2.5

—

Provisional assignment of new diseases of uncertain etiology

619

2430

2.59

103.00

2.5

—

Codes for special purposes

619

2430

2.59

103.00

2.5

—

Persons encountering health services in other circumstances, wide

1297

3378

2.01

102.75

2.4

2.5

—

Diseases of liver

397

1226

3.30

102.72

2.3

2.4

—

Heart failure, strict

478

1125

3.09

102.63

2.3

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

987

2875

2.17

100.39

2.4

2.5

—

987

2875

2.17

100.39

2.4

2.5

—

Hypertensive Renal Disease

17.57

100.21

2.1

2.4

—

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

174

187

7.04

99.21

2.2

2.4

—

Myelodysplastic syndrome, excluding all cancers (controls excluding all cancers)

20.98

99.10

2.8

2.4

—

All pneumoniae

1097

3728

2.05

98.41

2.4

2.5

—

Other respiratory diseases principally affecting the interstitium

202

398

5.19

96.70

2.2

2.4

—

Coagulation defects, purpura and other haemorrhagic conditions

297

796

3.83

95.96

2.5

—

Pneumonia, organism unspecified

944

3219

2.14

95.93

2.4

2.5

—

Cardiovascular diseases

937

2339

2.21

95.34

2.5

2.6

—

Medical observation and evaluation for suspected diseases and conditions

757

1612

2.43

93.73

2.5

2.4

—

Examination and observation for other reasons

660

1602

2.53

93.63

2.5

2.4

—

Maternal care for other known or suspected fetal problems

451

951

3.12

93.50

2.7

2.5

—

Intestinal infectious diseases

1040

4023

2.03

93.40

2.5

—

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)

11.44

93.12

2.3

2.2

—

Rare circulating lymphoid malignancy, excluding all cancers (controls excluding all cancers)

12.44

92.37

2.6

—

Inflammatory bowel disease treatment related agents

1266

3752

1.93

92.22

2.4

2.5

—

Dependence on enabling machines and devices, not elsewhere classified

31.38

92.05

3.0

2.2

—

ILD, hospital admissions 1, main diag only

166

289

5.90

91.12

2.2

2.3

—

Ascites

118

144

8.51

90.18

2.3

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

1031

3621

2.02

89.20

2.4

2.5

—

Postpartum care and examination

257

374

4.50

88.27

2.8

2.4

—

Other disorders of fluid, electrolyte and acid-base balance

283

742

3.73

88.25

2.3

2.4

—

ILD, hospital admissions

174

333

5.36

86.19

2.2

2.4

—

All-cause Heart Failure

443

1108

2.91

85.99

2.3

—

Interstitial lung disease endpoints

174

334

5.34

85.89

2.2

2.4

—

Interstitial lung disease

174

334

5.34

85.89

2.2

2.4

—

Other interstitial pulmonary diseases

174

334

5.34

85.89

2.2

2.4

—

Hepatocellular carcinoma, excluding all cancers (controls excluding all cancers)

18.31

85.81

2.3

—

Hernia of abdominal wall, postoperative

160

284

5.72

85.79

2.3

2.4

—

Second line medication for Crohn's disease

627

2700

2.35

85.12

2.5

—

Other obstetric conditions, not elsewhere classified

615

1645

2.48

84.25

2.8

2.6

—

L04AX Other immunosuppressants

607

2589

2.37

84.24

2.5

—

Disorders of lens

592

1500

2.51

83.86

2.3

2.4

—

Maternal care for known or suspected fetal abnormality and damage

310

817

3.48

83.78

2.8

2.5

—

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

19.04

83.48

3.5

2.2

—

Multiple myeloma

19.04

83.48

3.5

2.2

—

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

609

1629

2.48

83.31

2.8

2.6

—

Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)

12.10

83.23

2.6

2.2

—

Diffuse large B-cell lymphoma, helper endpoint

12.10

83.23

2.6

2.2

—

ILD, hospital admission 2, with pulmonary infections

126

182

7.13

83.09

2.2

2.3

—

Autoimmune diseases excluding thyroid diseases, strict definition

1138

3307

1.93

82.67

2.4

2.5

—

Autoimmune diseases excluding thyroid diseases

1152

3373

1.91

80.85

2.4

2.5

—

Purpura and other haemorrhagic conditions

211

502

4.33

80.52

2.5

2.4

—

Diseases of arteries, arterioles and capillaries (FINNGEN)

246

419

4.16

80.36

2.3

2.6

—

Thrombocytopenia, unspecified

137

225

6.36

80.24

2.5

—

Insulin, fast-acting

427

1578

2.75

80.22

2.4

2.5

—

Cardiomyopathy (excluding other)

164

318

5.29

80.09

2.4

—

Cardiomyopathies, Primary/intrinsic

161

309

5.34

79.55

2.4

—

Idiopathic pulmonary fibrosis

108

138

8.10

79.42

2.2

2.3

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

535

2039

2.45

79.21

2.4

—

Rare circulating lymphoid malignancy

103

9.88

78.82

2.6

2.5

—

Insulin, fast-acting or short human

429

1614

2.70

77.83

2.4

2.5

—

Oxycodone

314

961

3.20

77.36

2.6

2.4

—

223

570

4.02

77.24

2.5

2.6

—

Pregnancy examination and test

258

410

4.02

76.78

2.6

2.4

—

Presence of cardiac and vascular implants and grafts

286

626

3.49

75.75

2.4

2.2

—

Other special examinations and investigations of persons without complaint or reported diagnosis

714

1612

2.26

75.60

2.5

2.4

—

Fungal Sepsis

10.06

75.55

2.5

2.4

—

Hepatic failure, not elsewhere classified

9.88

75.30

2.3

2.5

—

Supervision of high-risk pregnancy

297

510

3.59

75.29

2.8

2.4

—

Hyperkalaemia

9.63

74.05

2.3

—

Implicit fungal Sepsis

10.42

73.84

2.4

2.3

—

Insulin, combination of fast acting with intermediate-acting or long-acting

587

2400

2.28

73.22

2.4

—

Malignant neoplasm, wide definition for exclusion

840

2440

2.05

73.18

2.6

2.4

—

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

840

2440

2.05

73.17

2.6

2.4

—

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

839

2438

2.05

73.02

2.6

2.4

—

Acute tubulo-interstitial nephritis

569

2206

2.31

72.85

2.4

2.5

—

Cardiomyopathy

195

472

4.21

72.48

2.5

2.4

—

Malignant neoplasm

813

2361

2.06

71.60

2.6

2.4

—

Other medical care

321

1056

3.00

71.19

2.4

2.5

—

Diarrhoea and gastroenteritis of presumed infectious origin

772

3499

2.02

70.97

2.5

—

Abnormal findings on diagnostic imaging of lung

366

1293

2.78

70.79

2.4

2.3

—

Oral corticosteroids

1061

3471

1.86

70.65

2.4

2.5

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

479

1208

2.54

69.56

2.4

2.6

—

Vitreous haemorrhage

151

310

5.03

69.28

2.4

—

Any reimbursement code in KELA

771

1846

2.11

69.20

2.5

2.6

—

Diffuse large B-cell lymphoma

9.22

68.74

2.6

2.3

—

Gingival hyperplasia

10.00

68.41

2.4

2.5

—

Insulin medication

587

2287

2.22

67.64

2.4

2.5

—

Atrial fibrillation and flutter

283

555

3.36

67.63

2.4

2.6

—

Non-ischemic cardiomyopathy

250

598

3.48

67.30

2.4

—

Disorders of choroid and retina

660

2274

2.13

66.76

2.3

2.4

—

Diabetic retinopathy, strict definition

233

587

3.58

65.92

2.4

—

Cholangitis (primary sclerosing, PSC)

110

177

6.47

65.73

2.4

2.5

—

Hypertensive heart and/or renal disease

203

398

4.00

65.60

2.1

2.4

—

Disorders of other endocrine glands

491

2099

2.33

65.33

2.4

2.5

—

Gout, idiopatic and unspecified

211

586

3.66

64.61

2.3

—

Outcome of delivery

245

423

3.66

64.46

3.0

2.4

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

548

2497

2.21

64.44

2.5

2.4

—

Non-Hodgkin lymphoma, all

9.73

64.11

2.9

2.3

—

Human immunodeficiency virus [HIV] disease

10.23

63.85

2.1

2.4

—

All influenza

281

939

3.04

63.83

2.5

—

Bronchitis

1056

3891

1.79

63.34

2.5

—

Gout, unspecified

179

451

4.04

63.06

2.3

—

Type 1 diabetes

341

1272

2.72

63.04

2.4

2.5

—

Diseases of oral cavity, salivary glands and jaws

839

2207

1.96

62.72

2.5

2.4

—

Neoplasms

968

2806

1.86

62.72

2.6

2.5

—

Other retinal disorders

495

1739

2.31

62.09

2.3

2.4

—

Need for immunization against other single viral diseases

10.55

61.98

2.3

—

Complications of medical and surgical care

657

3093

2.03

61.94

2.5

—

Autoimmune diseases

1161

3394

1.76

61.73

2.4

2.5

—

ILD, hospital admissions 3, with pneumonia sepsis

149

6.76

61.66

2.3

2.4

—

Other heart diseases, wide

951

3236

1.84

61.02

2.4

2.5

—

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

147

330

4.60

60.60

3.0

2.4

—

COPD/asthma related infections

1036

2886

1.81

60.26

2.5

—

COPD/asthma/ILD related infections

1036

2886

1.81

60.26

2.5

—

Type 2 diabetes, wide definition

634

1985

2.10

60.18

2.3

2.4

—

Pneumocystosis

14.46

59.70

2.3

2.4

—

Erosion of teeth

12.22

58.84

2.7

2.5

—

Other disorders of gingiva or/and edentulous alveolar ridge

148

6.69

58.65

2.5

2.4

—

Nausea and vomiting

294

1036

2.83

58.62

2.4

2.5

—

Statin medication

674

1851

2.06

58.62

2.2

2.5

—

Drug-induced cataract

9.95

58.23

2.4

—

Used for control exclusion in common control thyroid runs

1108

3229

1.75

58.01

2.4

2.5

—

Other diseases of pleura

335

1129

2.65

58.01

2.4

2.3

—

Congenital malformations, deformations and chromosomal abnormalities

708

3538

1.94

57.96

2.3

2.5

—

Protozoal diseases

8.76

57.56

2.5

2.4

—

Endocrine, nutritional and metabolic diseases

949

2658

1.83

57.44

2.5

2.6

—

Premature rupture of membranes

338

938

2.70

57.14

2.7

2.5

—

Acute upper respiratory infections of multiple and unspecified sites

808

3266

1.87

56.97

2.5

—

Insulin, intermediate and long-acting

483

2167

2.21

56.71

2.4

—

Human immunodeficiency virus [HIV] disease resulting in other conditions

10.52

56.60

2.1

2.4

—

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

149

6.57

56.03

2.3

—

ILD medications: pirfenidone

39.25

56.00

2.2

2.0

—

Diabetic retinopathy, excluding more controls

282

525

3.08

55.59

2.4

—

Chorioretinal inflammation

8.20

55.43

2.3

2.5

—

Cholangitis (primary sclerosing, PSC), with reimbursement 202

10.60

55.35

2.5

2.6

—

Bleeding

665

2464

1.98

55.25

2.4

—

Gout, strict definition

158

402

4.00

55.00

2.3

—

Other cataract

325

959

2.65

54.31

2.3

2.4

—

Care involving use of rehabilitation procedures

478

2099

2.18

54.21

2.3

2.5

—

Persons encountering health services for examination and investigation

651

1612

2.04

53.71

2.5

2.4

—

Disorders of lipoprotein metabolism and other lipidaemias

602

1857

2.05

53.62

2.3

2.4

—

Other bacterial intestinal infections

188

550

3.48

53.34

2.7

2.4

—

Antihypertensive medication - note that there are other indications

827

2458

1.86

53.32

2.4

2.6

—

Procreative management

360

1242

2.48

53.27

2.7

2.4

—

Parodontitis or operation codes

761

3028

1.86

53.21

2.4

—

Other diseases of biliary tract

104

196

5.44

52.59

2.4

—

Chronic periodontitis, including avohilmo

754

3019

1.86

52.50

2.4

—

Cardiomyopathy, other and unspecified

104

197

5.42

52.32

2.5

2.4

—

Parodontitis

757

3027

1.86

52.27

2.4

—

Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers

9.24

52.23

2.5

2.4

—

Complications of surgical and medical care, not elsewhere classified

889

3629

1.77

52.13

2.5

—

Adjustment and management of implanted device

131

304

4.36

51.50

2.4

—

Other disorders of skin and subcutaneous tissue

553

2522

2.02

51.37

2.4

—

Malignant neoplasm of liver and intrahepatic bile ducts

9.81

50.15

2.3

2.4

—

Viral pneumonia

161

445

3.70

49.94

2.5

2.4

—

Parodontitis and operation codes

708

2981

1.86

49.69

2.4

—

Sub-endpoint used in defining T1D endpoints

339

1392

2.43

49.59

2.3

2.5

—

Senile cataract

441

1222

2.25

49.54

2.2

2.4

—

Type 1 diabetes, wide definition, subgroup 1

278

1060

2.66

49.42

2.4

2.5

—

Viral infections characterized by skin and mucous membrane lesions

429

1985

2.18

49.24

2.4

2.5

—

Bacterial intestinal infections, IBD co-morbidities

186

569

3.32

49.21

2.7

2.3

—

Excluding asthma or asthma-COPD overlap

797

2185

1.84

48.99

2.4

2.5

—

Malaise and fatigue

378

1374

2.31

48.25

2.3

2.5

—

Other pulmonary diagnosis

794

2185

1.83

48.24

2.4

2.5

—

Type 1 diabetes, wide definition

287

1125

2.59

48.21

2.4

2.5

—

Gastrointestinal diseases

686

1804

1.92

47.93

2.5

2.6

—

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

274

911

2.66

47.90

2.5

2.3

—

Chronic tubulo-interstitial nephritis

7.97

47.84

2.2

2.6

—

Gout due to impairment of renal function

18.00

47.68

2.0

2.5

—

Renal tubulo-interstitial disorders in diseases classified elsewhere

20.63

47.17

2.3

2.5

—

Gingivitis and periodontal diseases

771

2195

1.82

46.65

2.4

—

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

435

970

2.27

46.62

2.4

2.6

—

Acquired haemolytic anaemia

8.99

46.45

2.6

2.5

—

Symptoms and signs involving the digestive system and abdomen

983

2923

1.69

46.01

2.4

2.5

—

Other necrotizing vasculopathies

176

5.38

45.85

2.4

2.5

—

Antenatal screening

268

544

2.81

45.62

2.6

2.4

—

COPD differential diagnosis

782

2187

1.80

45.16

2.4

2.5

—

ILD differential diagnosis

781

2186

1.80

44.98

2.4

2.5

—

Haemolytic anaemias

121

6.53

44.94

2.4

—

Unspecified nephritic syndrome

9.17

44.84

2.2

2.4

—

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

7.66

44.30

2.3

—

Disorders of calcium metabolism

160

5.54

44.23

2.5

2.4

—

Hypo-osmolality and hyponatraemia

134

353

3.84

44.23

2.3

2.4

—

Presence of other functional implants

288

802

2.56

44.22

2.2

—

Oedema, not elsewhere classified

231

843

2.75

44.21

2.5

—

IBD (strict) with PSC

14.27

44.20

2.5

2.7

—

Maternal care related to the fetus and amniotic cavity and possible delivery problems

483

1378

2.08

44.06

2.7

2.5

—

Other and unspecified disorders of white blood cells

117

6.51

43.92

2.3

2.5

—

Enterocolitis due to Clostridium difficile

117

283

4.22

43.77

2.9

2.4

—

Pneumonia due to other infectious organisms, not elsewhere classified

7.34

43.56

2.4

2.6

—

Heart failure and bmi 25plus

245

616

2.77

43.32

2.3

—

Disorders of mineral metabolism

104

232

4.60

43.26

2.5

2.4

—

Mycoses

267

1068

2.53

43.13

2.6

2.5

—

Diabetic retinopathy

303

772

2.51

43.06

2.3

—

Mantle cell lymphoma, excluding all cancers (controls excluding all cancers)

15.76

42.95

2.8

2.3

—

Streptococcal septicaemia

198

4.91

42.87

2.6

2.4

—

Alcoholic liver disease

115

280

4.20

42.71

2.3

—

Paroxysmal tachycardia

217

653

2.84

42.43

2.4

2.6

—

Acute upper respiratory infections

943

3599

1.65

42.13

2.5

—

False labour

389

1116

2.22

42.02

2.6

2.5

—

Colitis, primary sclerosing

10.50

41.88

2.5

2.6

—

ILD-related respiratory insufficiency

8.69

41.87

2.2

2.4

—

Other viral diseases, not elsewhere classified

235

896

2.66

41.76

2.5

2.6

—

Cerebrovascular diseases (FINNGEN)

246

662

2.68

41.48

2.4

2.6

—

Insulin, fast-acting (human)

207

745

2.83

41.44

2.4

2.5

—

Zoster [herpes zoster]

161

502

3.26

41.37

2.3

2.4

—

Drug-induced neutropenia

101

229

4.55

41.26

2.6

2.4

—

Hodgkin lymphoma

106

6.68

40.97

2.3

2.6

—

Follicular lymphoma

7.40

40.88

2.2

2.3

—

Pulmonary heart disease, diseases of pulmonary circulation

227

862

2.66

40.69

2.4

2.3

—

Other and unspecified types of non-Hodgkin lymphoma, hilmo

6.85

40.58

2.5

2.4

—

Supervision of normal pregnancy

249

528

2.73

40.50

2.6

2.4

—

Hepatocellular carcinoma

11.39

40.33

2.3

—

Congenital malformations of gallbladder, bile ducts and liver

13.27

40.17

2.4

2.3

—

Headache

581

2661

1.84

39.98

2.4

2.5

—

1017

3349

1.61

39.93

2.5

—

Hyperlipidaemia, other/unspecified

245

919

2.54

39.78

2.3

—

Other disorders of white blood cells

177

5.03

39.57

2.4

2.5

—

Erysipelas

340

1430

2.18

38.79

2.3

—

Explicit bacterial Sepsis

112

287

3.98

38.78

2.5

2.4

—

Ulcer of lower limb, not elsewhere classified

119

320

3.78

38.45

2.3

—

Atrial fibrillation and flutter with reimbursement

183

383

3.09

38.42

2.3

2.5

—

Other maternal disorders predominantly related to pregnancy

592

2047

1.83

38.19

2.7

2.5

—

Hypoplasia of dental enamel, including avohilmo

11.52

38.05

3.1

2.8

—

Tramadol

673

2477

1.76

38.04

2.3

2.5

—

Other abnormal products of conception

451

1520

2.00

38.03

2.8

2.5

—

Mature T/NK-cell lymphomas, hilmo, excluding all cancers

13.39

37.07

3.0

2.2

—

Diabetes mellitus in pregnancy

460

1540

1.96

36.41

2.7

2.6

—

Other and unspecified aplastic anaemias

14.21

36.13

2.6

2.9

—

Nutritional anaemias

351

1650

2.08

35.98

2.3

2.4

—

Follicular lymphoma, hilmo

6.40

35.77

2.2

2.4

—

Special screening examination for infectious and parasitic diseases

339

1189

2.16

35.76

2.8

2.5

—

Venous thromboembolism

365

1743

2.05

35.62

2.4

—

Dental caries 2

781

3766

1.64

35.59

2.6

2.5

—

Single delivery by caesarean section

253

588

2.53

35.58

2.8

2.5

—

Dental caries 2 and operation codes

772

3755

1.64

35.58

2.6

2.5

—

Other diseases of the respiratory system

153

507

3.05

35.49

2.4

—

Other respiratory disorders and diseases

153

507

3.05

35.49

2.4

—

Hodgkin lymphoma, hilmo

123

5.74

35.26

2.3

2.5

—

Other and unspecified polyneuropathies, also in other diseases

155

522

3.01

35.00

2.3

2.4

—

Diseases of the eye and adnexa

907

2840

1.61

34.96

2.4

2.6

—

Osteopathies and chondropathies

431

2143

1.92

34.93

2.4

—

Diseases of oesophagus, stomach and duodenum

918

3533

1.59

34.91

2.4

2.5

—

Respiratory insufficiency

113

5.74

34.62

2.4

2.5

—

Spontaneous abortion

496

1822

1.87

34.58

2.7

2.5

—

Iron deficiency anaemia

312

1452

2.15

34.57

2.3

2.5

—

Personal history of other diseases and conditions

159

549

2.94

34.19

2.6

—

Mature T/NK-cell lymphomas, hilmo

11.75

34.17

3.0

2.4

—

Amiodarone users

234

4.10

33.94

2.3

—

Pacemaker

183

667

2.69

33.52

2.4

2.3

—

Molar incisor enamel hypoplasia, with caries

15.07

33.51

3.2

2.8

—

Other diseases of liver

168

607

2.81

33.42

2.3

2.4

—

COPD-related respiratory insufficiency

250

3.94

33.35

2.1

2.3

—

Abdominal and pelvic pain

915

2920

1.58

33.13

2.4

2.5

—

Neurotic, stress-related and somatoform disorders

862

3903

1.58

33.12

2.5

—

Any event in cancer register

816

3017

1.61

33.08

2.6

2.5

—

Anxiety disorders

866

3916

1.58

33.01

2.5

—

Gestational diabetes (for exclusion)

511

2009

1.82

32.98

2.7

2.6

—

L01XE Protein kinase inhibitors

153

4.91

32.89

2.4

—

Mantle cell lymphoma

17.12

32.70

2.9

2.6

—

Sarcoidosis

139

459

3.08

32.59

2.4

—

Delivery, wide proxy

279

643

2.33

32.53

2.6

2.4

—

Valvular heart disease excluding rheumatic fever

324

1130

2.11

32.46

2.4

—

Ulcerative colitis (strict) with PSC

12.69

32.36

2.4

2.8

—

Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

7.60

32.34

2.5

2.2

—

Polyneuropathies and other disorders of the peripheral nervous system

170

629

2.74

32.28

2.3

—

Diagnoses used for exclusion with ILD

198

790

2.53

32.25

2.4

—

Colitis, primary sclerosing, strict definition

10.38

32.00

2.5

2.6

—

Seborrhoeic keratosis

153

539

2.87

31.86

2.3

—

Diseases of arteries, arterioles and capillaries

432

1721

1.88

31.72

2.3

2.4

—

Heart failure and hypertrophic cardiomyopathy

10.57

31.21

2.3

—

Diabetes, varying definitions

881

3391

1.56

31.16

2.4

2.5

—

Pure hypercholesterolaemia

452

1642

1.86

31.07

2.2

2.4

—

Infections of the skin and subcutaneous tissue

536

3113

1.73

30.89

2.4

2.5

—

Bacterial pneumonia (organism specified)

332

1515

2.01

30.57

2.4

—

Diseases of the skin and subcutaneous tissue

946

3098

1.54

30.33

2.5

—

Viral pneumonia (known virus, not influenza)

6.83

30.10

2.8

2.5

—

Other reaction to severe stress, and adjustment disorders

423

2324

1.84

30.08

2.5

—

Dermatitis and eczema

960

4182

1.51

30.04

2.5

—

Other infectious diseases

247

3.81

29.99

2.4

—

Non-rheumatic valve diseases

313

1113

2.07

29.78

2.3

2.4

—

Isolated proteinuria

120

5.33

29.77

2.4

2.5

—

Maternal care for known or suspected malpresentation of fetus

247

821

2.28

29.71

2.7

2.5

—

Other acute lower respiratory infections

452

2419

1.80

29.69

2.5

—

Polyarthropathies

632

2548

1.66

29.66

2.3

2.5

—

Iridocyclitis

213

915

2.36

29.60

2.2

2.5

—

Diabetes mellitus

882

3432

1.54

29.59

2.4

2.5

—

Systemic connective tissue disorders

271

1286

2.13

29.46

2.4

2.5

—

Continuous positive airway pressure

156

494

2.75

29.12

2.4

—

Osteoporosis

156

554

2.71

28.96

2.4

2.3

—

Habitual aborter

143

4.91

28.95

3.0

2.7

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

428

2384

1.81

28.93

2.3

2.5

—

Diseases of the digestive system

336

1731

1.95

28.86

2.4

—

Retinal detachments and breaks

220

971

2.28

28.63

2.3

—

Melanocytic naevi

266

1271

2.11

28.47

2.6

2.5

—

Other pleural conditions

206

3.99

28.43

2.4

2.3

—

Other diseases of the digestive system

220

975

2.27

28.36

2.4

—

Ischaemic heart disease, wide definition

495

1770

1.76

28.20

2.2

2.4

—

Benign neoplasm of colon, rectum, anus and anal canal

316

1125

2.02

28.16

2.3

—

Benign neoplasm: Colon

270

979

2.13

28.03

2.3

—

Other diseases of pericardium

100

5.55

27.99

2.2

2.4

—

Disorders of vitreous body and globe

308

1524

1.98

27.75

2.3

2.4

—

Postpartum haemorrhage

315

1397

1.99

27.68

2.8

2.5

—

Other necrotizing vasculopathies (FG)

143

4.65

27.62

2.4

2.5

—

Symptoms and signs involving the circulatory and respiratory systems

1004

3403

1.49

27.42

2.4

2.5

—

Nonischemic cardiomyopathy

173

4.27

27.40

2.4

—

Anxiety disorders, excluding more controls

778

3346

1.55

27.36

2.5

—

L01XX Other antineoplastic agents

121

4.99

27.27

2.6

2.4

—

Autoimmune diseases related-to ILD

717

4063

1.56

27.25

2.4

2.5

—

Secondary right heart disease

5.92

27.22

2.4

—

Abnormal findings on examination of urine, without diagnosis

167

4.33

26.97

2.5

—

Ischemic heart diseases

503

1834

1.73

26.87

2.2

2.4

—

Isolated proteinuria with specified morphological lesion

9.86

26.85

2.2

2.5

—

GI-bleeding

216

977

2.23

26.54

2.4

—

All influenza (not pneumonia)

153

595

2.61

26.45

2.6

2.4

—

Symptoms and signs involving the skin and subcutaneous tissue

554

3381

1.64

26.44

2.5

—

Disorders of sclera, cornea, iris and ciliary body

450

2618

1.73

26.30

2.3

2.5

—

Other problems related to primary support group, including family circumstances

176

716

2.44

26.20

2.8

2.6

—

Dyspnoea

687

3374

1.57

26.09

2.3

2.5

—

Osteonecrosis

159

4.32

25.92

2.7

2.4

—

Disorders of vitreous body

294

1473

1.97

25.88

2.3

2.4

—

Myelodysplastic syndrome

18.75

25.76

2.5

2.9

—

Charcot foot

7.91

25.72

2.5

—

Perineal laceration during delivery

256

1113

2.09

25.65

2.7

2.6

—

Pulmonary embolism

187

808

2.33

25.64

2.4

2.3

—

Single delivery by forceps and vacuum extractor

199

514

2.39

25.55

2.6

2.5

—

Coronary atherosclerosis

418

1513

1.79

25.51

2.2

2.4

—

DVT of lower extremities and pulmonary embolism

259

1274

2.04

25.38

2.5

2.4

—

Complications of labour and delivery

559

1889

1.66

25.23

2.7

2.5

—

Maternal care for known or suspected abnormality of pelvic organs

282

969

2.03

25.22

2.8

2.5

—

Dermatitis

482

2891

1.68

25.15

2.4

2.5

—

Benign neoplasms

783

2915

1.53

25.08

2.5

—

Bacterial pneumoniae

283

1274

1.98

24.98

2.4

2.5

—

Pulmonary heart disease

187

818

2.30

24.93

2.4

2.3

—

Other autoimmune haemolytic anaemias

11.06

24.71

2.5

2.6

—

Pregnancy, childbirth and the puerperium

221

511

2.28

24.67

2.6

2.4

—

Bacterial pneumonia, not elsewhere classified

267

1183

2.01

24.64

2.4

2.5

—

Other diseases of urinary system

893

3418

1.48

24.33

2.5

—

Amputation

212

3.68

24.18

2.2

2.3

—

Dental operations

466

1387

1.73

24.17

2.4

—

Other metabolic disorders

130

490

2.69

24.01

2.6

—

Other pulmonary heart/vessel disease

5.23

23.89

2.4

—

Acute bronchitis

320

1697

1.86

23.87

2.4

2.5

—

Type 2 diabetes

757

2974

1.52

23.86

2.4

2.5

—

Disorders of tooth development and eruption

246

3.45

23.78

2.9

2.5

—

Any operation in hilmo

9.00

23.76

2.5

—

Parasetamol

809

2757

1.50

23.69

2.4

2.5

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

713

2852

1.53

23.68

2.3

2.5

—

Reimbursement for rheumatic diseases

441

2621

1.69

23.66

2.3

2.5

—

Chronic hepatitis, not elsewhere classified

113

4.85

23.53

2.3

2.5

—

Hypertensive Heart Disease

122

359

2.80

23.41

2.1

2.4

—

Filling of root of tooth

118

4.76

23.32

2.5

—

Pleural effusion

322

3.08

23.25

2.2

2.3

—

Anterior Iridocyclitis

185

832

2.25

23.22

2.2

2.5

—

Myeloproliferative diseases

209

3.65

23.21

2.5

2.4

—

Gastroduodenal ulcer

153

633

2.43

23.05

2.3

—

Aspergillosis

11.37

23.01

3.0

2.5

—

Acute and subacute iridocyclitis

177

785

2.28

22.98

2.2

2.5

—

Peripheral artery disease

228

889

2.08

22.63

2.2

2.3

—

Peripheral artery operations in Hilmo

261

3.29

22.56

2.2

2.3

—

Other and unspecified iron deficiency

234

1165

2.02

22.48

2.3

2.5

—

Myocarditis

114

4.65

22.21

2.4

2.7

—

Opioids

922

3367

1.44

22.15

2.3

2.5

—

Early onset COPD, excluding more controls

132

522

2.55

22.04

2.2

2.4

—

Hepatomegaly and splenomegaly, not elsewhere classified

9.95

22.02

2.3

2.2

—

Other and unspecified dermatitis

399

2367

1.70

21.83

2.4

2.5

—

Diseases of the respiratory system

575

1815

1.59

21.75

2.5

—

Unspecified human immunodeficiency virus [HIV] disease

8.43

21.58

2.1

2.6

—

Malignant immunoproliferative diseases

12.36

21.57

2.6

2.2

—

Poor fetal growth

204

988

2.11

21.43

2.5

2.7

—

Single spontaneous delivery

301

849

1.90

21.21

2.6

2.4

—

Other gastritis (incl. Duodenitis)

156

680

2.31

21.09

2.3

—

Complications of procedures, not elsewhere classified

594

3374

1.53

20.71

2.4

2.5

—

Asthma, excluding more controls

598

2062

1.55

20.52

2.4

2.5

—

Chronic myeloid leukaemia, excluding all cancers (controls excluding all cancers)

13.27

20.50

2.2

2.3

—

Hydronephrosis

293

3.04

20.49

2.3

2.4

—

Amputation of toe

161

3.86

20.47

2.2

2.3

—

Arthropathies in other diseases classified elsewhere

114

4.51

20.46

2.4

2.6

—

Cardiac arrhythmias

535

2258

1.57

20.34

2.5

—

Melanocytic naevi

266

1434

1.87

20.32

2.6

2.5

—

Other skin changes

129

526

2.48

20.31

2.4

—

Haemorrhage in early pregnancy

276

1469

1.85

20.24

2.7

2.6

—

Viral warts

120

475

2.57

20.22

2.4

2.5

—

Delivery

299

850

1.87

20.20

2.6

2.4

—

Iron deficiency anaemia secondary to blood loss (chronic)

113

434

2.63

20.14

2.3

2.4

—

Unspecified jaundice

107

4.57

20.13

2.4

2.5

—

Diabetes, insulin treatment (Kela reimbursement)

733

3060

1.47

20.09

2.3

2.5

—

Other congenital malformations of the digestive system

200

3.53

20.07

2.5

—

Osteonecrosis due to drugs

9.12

19.98

2.7

2.4

—

ILD medications: nintedanib

35.57

19.81

2.4

2.0

—

Symptoms and signs involving the urinary system

521

2589

1.56

19.78

2.3

2.5

—

Hypothyroidism (congenital or acquired)

316

1008

1.81

19.72

2.5

2.6

—

Follow-up examination after treatment for conditions other than malignant neoplasms

355

1347

1.74

19.71

2.5

—

Pre-eclampsia or poor fetal growth

342

2001

1.72

19.66

2.5

2.6

—

Hypersensitivity angiitis

15.28

19.63

2.3

2.1

—

Phlebitis and thrombophlebitis (not including DVT)

162

743

2.20

19.44

2.4

—

Encephalopathy

9.80

19.31

2.4

2.3

—

Abnormalities of breathing

811

3381

1.43

19.17

2.3

2.5

—

Cellulitis

186

907

2.07

19.08

2.3

2.5

—

Glucagon-like peptide-1 (GLP-1) analogues

312

1465

1.76

19.05

2.3

2.4

—

Haemorrhage, not elsewhere classified

5.77

19.04

2.3

2.5

—

Marginal zone B-cell lymphoma, excluding all cancers (controls excluding all cancers)

8.93

19.03

2.3

—

Female infertility

380

1399

1.69

18.93

2.7

2.6

—

Chronic myeloproliferative disease

8.06

18.87

2.9

2.3

—

Localized swelling, mass and lump of skin and subcutaneous tissue

239

1277

1.89

18.79

2.5

—

Candidiasis

135

584

2.34

18.73

2.7

2.5

—

Stomatitis and related lesions

304

2.91

18.68

2.4

2.5

—

Cystitis

701

2944

1.46

18.65

2.5

—

Gastric ulcer

107

417

2.59

18.53

2.3

—

Unspecified haematuria

251

1162

1.86

18.52

2.3

2.4

—

Other and unspecified diseases of blood and blood-forming organs

5.65

18.49

2.2

2.4

—

Dental caries 1 and operation codes

660

2287

1.49

18.43

2.4

2.5

—

Persons encountering health services in circumstances related to reproduction

461

1977

1.59

18.39

2.5

2.4

—

Background retinopathy and retinal vascular changes

6.15

18.37

2.2

2.3

—

Other CVD (FINNGEN)

176

3.30

18.35

2.1

2.5

—

Diabetes medication

812

3494

1.42

18.35

2.4

2.5

—

Other diseases of lip and oral mucosa

108

427

2.55

18.19

2.4

—

Erectile dysfunction

204

3.34

18.19

2.3

—

Postprocedural endocrine and metabolic disorders, not elsewhere classified

110

441

2.53

18.04

2.6

—

Acute nephritic syndrome

5.27

18.04

2.2

2.5

—

Erosion of teeth, including avohilmo

196

959

1.99

18.03

2.7

2.4

—

Primary biliary cholangitis (PBC)

6.87

17.95

2.6

2.7

—

Other inflammatory liver diseases

221

3.23

17.95

2.3

2.5

—

Abnormal findings on examination of blood, without diagnosis

302

1645

1.73

17.65

2.4

—

Asthma

601

2165

1.49

17.47

2.4

2.5

—

Diseases of spleen

5.87

17.44

2.4

2.6

—

Diabetic neuropathy

106

423

2.53

17.39

2.4

2.3

—

Gastro-oesophageal reflux disease

455

2603

1.55

17.38

2.5

2.4

—

Haemorrhage from respiratory passages

208

1007

1.93

17.37

2.3

2.4

—

Other complications of labour and delivery, not elsewhere classified

185

900

2.02

17.34

2.8

2.6

—

Osteopathy in diseases classified elsewhere

12.10

17.30

2.9

2.5

—

Acute lymphocytic leukaemia, excluding all cancers (controls excluding all cancers)

7.87

17.30

2.6

2.5

—

Acute lymphocytic leukaemia, helper endpoint

7.87

17.30

2.6

2.5

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

668

3012

1.45

17.28

2.4

—

Benign neoplasm: Colon

270

1504

1.77

17.24

2.3

—

Asthma (only as main-diagnosis), excluding more controls

526

2062

1.53

17.22

2.4

2.5

—

Other congenital malformations of urinary system

9.79

17.13

3.0

2.4

—

Retinal vascular occlusion

222

3.14

17.09

2.3

—

Acute lymphadenitis

298

2.85

17.06

2.4

2.5

—

Asthma, unspecified (mode), excluding more controls

346

1644

1.66

17.00

2.4

2.5

—

Other disorders of urethra and urinary system

516

2566

1.51

16.96

2.5

—

Retinal vascular disorders

223

3.12

16.96

2.3

—

Benign neoplasm: Transverse colon

169

3.47

16.85

2.2

2.3

—

Secondary thrombocytopenia

8.06

16.71

2.4

2.6

—

Chronic gastritis

151

716

2.12

16.69

2.3

—

Thrombotic microangiopathy

11.47

16.65

2.5

2.7

—

Other or ill-defined heart diseases

161

3.54

16.65

2.3

2.5

—

Chronic myeloid leukaemia [CML], BCR/ABL-positive

9.64

16.60

2.2

2.4

—

Idiopathic gout

206

3.20

16.55

2.1

2.3

—

Noninfective enteritis and colitis

377

2372

1.60

16.42

2.5

—

Maternal care for other conditions predominantly related to pregnancy

242

1339

1.80

16.40

2.6

—

Fibrosis of liver

12.19

16.40

2.4

2.5

—

Benign neoplasm of other and ill-defined parts of digestive system

366

2.59

16.37

2.3

2.4

—

Viral and other specified intestinal infections

247

1365

1.78

16.19

2.5

—

Benign neoplasm of colon, rectum, anus and anal canal

323

1767

1.66

16.16

2.3

—

Atherosclerosis, excluding cerebral and coronary sclerosis

187

764

1.96

16.16

2.3

—

Pregnancy with abortive outcome

568

2005

1.49

16.12

2.6

2.5

—

Covid-19 suspected case

220

1206

1.84

16.10

2.6

2.5

—

Heart failure and coronary heart disease

147

511

2.16

16.02

2.2

2.3

—

Hypothyroidism, levothyroxine purchases

300

1007

1.73

15.95

2.5

2.6

—

Hypothyroidism and >3 levothyroxin purchases

300

1007

1.73

15.95

2.5

2.6

—

Molar incisor enamel hypoplasia

168

3.44

15.90

2.9

2.6

—

Malignant immunoproliferative diseases

8.07

15.89

2.6

2.4

—

Other and unspecified coagulation defects

197

3.22

15.82

2.6

2.5

—

Neovascular glaucoma

111

4.05

15.82

2.4

2.5

—

Glaucoma secondary to other eye disorders

111

4.05

15.82

2.4

2.5

—

Renal agenesis and other reduction defects of kidney

11.67

15.79

1.9

3.5

—

Melanocytic naevi of trunk

108

458

2.39

15.76

2.5

—

Unspecified contracted kidney

11.51

15.75

2.1

2.6

—

Pericarditis

4.43

15.74

2.3

—

Acute lymphocytic leukaemia

7.05

15.71

2.6

2.5

—

Postpartum hemorraghe, all women as controls

315

1916

1.65

15.68

2.8

2.6

—

Volume depletion

208

3.11

15.63

2.5

2.4

—

Non-invasive ventilation

169

803

1.99

15.58

2.4

2.5

—

Hypoplasia of dental enamel , including avohilmo

153

3.55

15.49

2.9

2.6

—

Benign neoplasms

891

3674

1.36

15.49

2.5

—

Viral pneumonia (unknown virus, not influenza)

280

2.80

15.47

2.3

2.4

—

Excessive attrition of teeth

336

1106

1.66

15.32

2.5

2.4

—

Symptoms and signs concerning food and fluid intake

281

2.77

15.26

2.2

2.5

—

Cardiac arrest

4.03

15.22

2.5

2.6

—

Other coagulation defects

283

2.77

15.16

2.6

2.4

—

Female infertility, cervigal, vaginal, other or unspecified origin

331

1360

1.64

15.13

2.7

2.6

—

Asthma (mode)

578

2186

1.46

15.00

2.4

2.5

—

Disorders of gallbladder, biliary tract and pancreas

684

3149

1.40

14.96

2.4

2.5

—

Dental caries 3 and operation codes

693

2527

1.41

14.94

2.4

2.5

—

Opening and dilatation of root channel of tooth

303

2.69

14.89

2.6

2.5

—

Asthma, unspecified (mode)

346

1719

1.60

14.88

2.4

2.5

—

Dentofacial anomalies [including malocclusion]

233

1315

1.76

14.88

2.6

2.5

—

Hypertrophic cardiomyopathy

121

3.81

14.84

2.3

2.5

—

Other and unspecified acquired haemolytic anaemias

9.48

14.80

2.2

2.4

—

Congenital malformation of biliary tract

13.57

14.79

2.8

2.4

—

Syncope and collapse

253

1304

1.73

14.78

2.4

2.5

—

Pain, not elsewhere classified

195

1057

1.86

14.78

2.4

2.6

—

Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)

130

3.64

14.76

2.2

—

Disorders of lacrimal system

269

1602

1.69

14.72

2.4

2.5

—

Other specified and unspecified retinal disorders

4.21

14.72

2.3

2.4

—

Labour and delivery complicated by fetal stress [distress]

299

1202

1.68

14.72

2.7

2.6

—

Asthma (only as main-diagnosis)

526

2165

1.47

14.60

2.4

2.5

—

Benign neoplasm: Sigmoid colon

329

2.57

14.51

2.3

—

Osteomyelitis

197

3.10

14.48

2.3

—

Other disorders of skin and subcutaneous tissue, not elsewhere classified

102

439

2.35

14.40

2.4

—

AV-block

313

2.54

14.37

2.4

2.3

—

Carcinoma in situ of skin

4.25

14.33

2.5

2.3

—

Other specified disorders of kidney and ureter

4.12

14.33

2.3

2.5

—

Chronic iridocyclitis

183

3.18

14.32

2.1

2.6

—

Other disorders of lacrimal gland

226

1294

1.76

14.30

2.4

2.5

—

All anxiety disorders

581

3297

1.42

14.29

2.5

—

SLE (Finngen)

106

3.96

14.29

2.1

2.6

—

Budesonide

121

564

2.17

14.14

2.6

—

Haemolytic-uraemic syndrome

12.66

14.13

2.6

2.5

—

Medical treatment for female infertility

257

1529

1.69

14.12

2.7

2.6

—

Acute sinusitis

456

2886

1.48

14.01

2.5

—

Toxoplasmosis

9.67

13.97

3.1

—

Other embolism and thrombosis

390

2.41

13.94

2.3

2.4

—

Other CVD

422

2.34

13.80

2.2

2.4

—

Cutaneous abscess, furuncle and carbuncle

216

1235

1.76

13.78

2.5

—

Unspecified acute lower respiratory infection

128

618

2.09

13.66

2.7

2.4

—

Acquired absence of organs, not elsewhere classified

7.91

13.66

2.1

2.2

—

Dental pulpitis 1

886

3458

1.33

13.64

2.4

2.5

—

Other mycoses, not elsewhere classified/unspecified

14.71

13.62

2.5

3.1

—

Visual disturbances and blindness

347

2243

1.55

13.61

2.4

2.5

—

Other disorders of amniotic fluid and membranes

153

782

1.96

13.59

2.7

2.5

—

Diseases of pulp and periapical tissues, including avohilmo

885

3455

1.33

13.59

2.4

2.5

—

Carcinoma in situ of skin of other and unspecified parts of face

4.96

13.57

2.3

2.2

—

Dental pulpitis 4

885

3458

1.33

13.51

2.4

2.5

—

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

318

2000

1.59

13.46

2.6

—

Persons encountering health services in other circumstances

295

1841

1.61

13.44

2.3

2.5

—

Papilloedema, unspecified

4.02

13.38

2.3

2.6

—

Melanocytic naevi, other sites/unspecified

297

2.60

13.30

2.4

—

Abnormal findings on diagnostic imaging of other body structures

381

2.39

13.24

2.4

—

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

192

3.01

13.17

2.7

2.4

—

Pain (limb, back, neck, head abdominally)

631

2261

1.40

13.15

2.5

—

Complications of cardiac and vascular prosthetic devices, implants and grafts

5.60

13.14

2.2

2.3

—

Presence of other devices

396

2.33

12.97

2.4

2.2

—

Benign neoplasm: Colon, unspecified

102

457

2.23

12.95

2.3

—

Other diseases of arteries and capillaries

266

2.66

12.94

2.3

2.4

—

Anxiety (asthma-related co-morbidities)

569

3208

1.40

12.94

2.5

—

Dysphagia

136

686

1.99

12.86

2.4

—

Persons encountering health services for specific procedures, not carried out

273

2.64

12.84

2.4

2.5

—

Dental pulpitis 2

494

1740

1.46

12.80

2.4

—

Other diseases of blood and blood-forming organs

201

2.93

12.78

2.3

2.4

—

Benign neoplasm: Stomach

169

3.11

12.77

2.2

2.3

—

Retinal haemorrhage

5.23

12.75

2.6

2.4

—

Pulmonary oedema

7.21

12.75

2.2

2.8

—

Other interventions on the root canals of the tooth

4.21

12.71

2.4

2.6

—

Amputation of ankle bones

5.60

12.65

2.2

2.4

—

Other noninfective gastroenteritis and colitis

185

1037

1.80

12.63

2.5

—

Cardiodefibrillation

178

985

1.81

12.62

2.4

2.3

—

Other diseases of stomach and duodenum

145

3.28

12.60

2.3

—

Idiopathic thrombocytopenic purpura

112

3.67

12.51

2.4

2.5

—

Visual impairment including blindness (binocular or monocular)

182

3.01

12.49

2.2

2.5

—

COPD (mode)

134

531

2.01

12.49

2.2

2.4

—

Disorders of oesophagus in diseases classified elsewhere

5.76

12.49

2.4

2.5

—

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

10.42

12.32

2.8

2.3

—

Endocarditis

4.03

12.23

2.2

2.4

—

Asthma-related pneumonia

219

1300

1.69

12.17

2.4

2.5

—

Left ventricular outflow tract obstruction (LVOTO), broad definition

428

2.25

12.17

2.6

2.4

—

Cardiomyopathy, Hypertrophic obstructive

5.37

12.09

2.3

2.6

—

Asthma-related pneumonia or sepsis

219

1305

1.68

12.00

2.4

2.5

—

Asthma, hospital admissions 3, pneumonia

219

1305

1.68

12.00

2.4

2.5

—

Traction detachment of retina

7.30

11.99

2.5

2.4

—

Other disorders of optic [2nd] nerve and visual pathways

237

2.70

11.95

2.2

2.5

—

Acute posthaemorrhagic anaemia

4.47

11.94

2.2

2.3

—

Disseminated intravascular coagulation [defibrination syndrome]

13.35

11.94

2.4

2.2

—

Arterial embolism and thrombosis

120

3.46

11.93

2.2

2.4

—

Antepartum haemorrhage, not elsewhere classified

100

465

2.18

11.88

2.7

2.5

—

Systemic lupus erythematosus

121

3.46

11.85

2.1

2.6

—

Hypokalaemia

302

2.47

11.84

2.5

2.4

—

Hernia of abdominal wall

286

1832

1.57

11.77

2.4

—

Retinal detachment with retinal break

321

2.42

11.76

2.4

2.3

—

Myeloproliferative diseases (CML excluded)

194

2.87

11.75

2.6

2.4

—

Cerebral cysts

245

2.66

11.75

2.5

—

Other diseases of intestines

881

3945

1.30

11.69

2.4

2.5

—

Syphilis

3.99

11.63

2.2

2.3

—

Failed induction of labour

406

2.26

11.60

2.9

2.6

—

Parodontitis or/and operation codes

535

2277

1.40

11.59

2.4

2.5

—

Other leukaemias of specified cell type

29.63

11.58

2.8

2.0

—

Depression

788

4142

1.31

11.52

2.4

2.5

—

Umbilical hernia

197

1157

1.71

11.51

2.4

2.5

—

Inflammatory diseases of the central nervous system

332

2.38

11.43

2.4

—

Hard cardiovascular diseases

445

1987

1.44

11.43

2.3

2.4

—

Prolonged pregnancy

165

842

1.81

11.33

2.6

2.5

—

Abnormal findings on antenatal screening of mother

130

679

1.95

11.32

2.8

2.7

—

STROKE

330

1508

1.52

11.31

2.4

2.5

—

Osteoporosis with pathological fracture (FG)

3.68

11.23

2.4

—

Cough

270

1654

1.57

11.23

2.5

—

Encephalitis

106

3.58

11.22

2.4

2.6

—

Other benign neoplasms of skin

189

1083

1.72

11.21

2.5

2.4

—

Family history of certain disabilities and chronic diseases leading to disablement

211

2.75

11.20

3.2

2.5

—

Other symptoms and signs involving the digestive system and abdomen

108

529

2.06

11.16

2.3

2.4

—

Other renal tubulo-interstitial diseases

4.34

11.08

2.3

2.6

—

Herpesviral [herpes simplex] infections

100

478

2.11

11.07

2.3

2.4

—

Actinic keratosis

134

672

1.90

11.03

2.2

—

Glaucoma

262

1460

1.58

11.01

2.3

—

Hypotension

331

2.34

10.99

2.1

2.3

—

Long labour

239

1299

1.62

10.98

2.6

2.5

—

Immunodeficiency with predominantly antibody defects

3.71

10.87

2.6

—

Abnormal results of function studies

315

2.38

10.86

2.5

2.4

—

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma, excluding all cancers (controls excluding all cancers)

9.75

10.86

2.6

2.3

—

Dental caries, including avohilmo

543

2006

1.39

10.81

2.5

2.4

—

Microscopic polyangiitis

8.81

10.75

2.4

2.3

—

Dental caries 1

543

2008

1.39

10.74

2.5

2.4

—

Neurological diseases, wide definition

364

1227

1.50

10.73

2.5

2.6

—

Skin changes due to chronic exposure to nonionizing radiation

138

703

1.86

10.71

2.2

—

Other local infections of skin and subcutaneous tissue

380

2.24

10.70

2.5

2.4

—

Other and unspecified local infections of skin and subcutaneous tissue

361

2.27

10.70

2.5

2.4

—

Aortic valve malfunction, age under 60 years

387

2.22

10.68

2.4

—

Hypertension, Pulmonary Arterial

7.83

10.65

2.6

3.4

—

Benign neoplasm: Skin of other and unspecified parts of face

257

2.51

10.64

2.5

2.4

—

Dental caries 2, only avohilmo

649

3860

1.33

10.63

2.6

2.5

—

SLE, strict definition

120

3.32

10.59

2.1

2.6

—

SLE, ICD10

120

3.32

10.59

2.1

2.6

—

Polyhydramnios

241

2.58

10.57

2.5

2.6

—

Wegener granulomatosis

4.78

10.57

2.3

2.5

—

Other and unspecified vascular occlusions

167

2.90

10.53

2.3

—

Other encephalitis

101

3.55

10.51

2.4

2.6

—

Polycythaemia vera

4.69

10.50

2.4

2.2

—

Urolithiasis

195

1172

1.67

10.49

2.4

—

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

180

816

1.73

10.49

2.4

2.2

—

Drug-induced osteoporosis with pathological fracture

6.18

10.46

2.6

2.3

—

Disorders of plasma-protein metabolism, not elsewhere classified

6.69

10.41

2.5

2.9

—

Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)

235

998

1.61

10.35

2.3

—

Explicit fungal Sepsis

9.15

10.33

2.6

2.7

—

Other leukaemias of specified cell type

19.69

10.29

2.8

2.1

—

Shock, not elsewhere classified

8.97

10.29

2.2

2.5

—

Hypertension, portal

19.24

10.23

2.0

2.3

—

Complications predominantly related to the puerperium

260

1689

1.55

10.19

2.7

2.6

—

Recurrent and persistent haematuria

6.11

10.19

2.1

2.6

—

Conjunctivitis (acute, non atopic)

229

1441

1.59

10.14

2.5

—

Melanocytic naevi, other sites/unspecified

338

2.28

10.13

2.4

—

Disorder of lipoprotein metabolism, unspecified

288

2.38

10.08

2.4

—

Other and unspecified iridocyclitis

161

2.91

10.06

2.2

2.5

—

Persons with potential health hazards related to communicable diseases

400

2816

1.42

9.98

2.3

2.6

—

Depression medications

316

1054

1.52

9.95

2.4

2.6

—

Convulsions, not elsewhere classified

170

987

1.71

9.94

2.3

2.6

—

Dermatitis due to substances taken internally

207

2.65

9.94

2.5

—

Sequelae of external causes of morbidity and mortality

154

882

1.76

9.92

2.4

—

Injury, poisoning and certain other consequences of external causes

516

1883

1.38

9.85

2.4

2.6

—

Diverticular disease of intestine

367

1688

1.45

9.81

2.3

2.4

—

Marginal zone B-cell lymphoma

7.70

9.78

2.1

2.4

—

Infections with a predominantly sexual mode of transmission

319

2180

1.47

9.77

2.5

2.6

—

Other arterial embolism and thrombosis

4.14

9.74

2.3

2.4

—

Melanocytic naevi of trunk

108

558

1.96

9.72

2.5

—

Immunodeficiencies

181

2.75

9.71

2.4

2.5

—

Mood disorders, excluding more controls

732

3441

1.30

9.70

2.4

2.5

—

Conduction disorders

145

677

1.79

9.67

2.4

—

Tuberculosis of other organs, strict

4.86

9.57

2.3

2.4

—

Disorders of skin appendages

387

2752

1.41

9.54

2.4

2.5

—

Acute pancreatitis

117

624

1.89

9.53

2.4

—

Calculus of kidney and ureter

181

1096

1.66

9.52

2.4

—

6-mercaptopurine

145

2.96

9.46

2.5

—

Other abnormalities of plasma proteins

5.30

9.43

2.4

2.5

—

Benign neoplasm: Rectum

335

2.22

9.42

2.3

—

Degeneration of macula and posterior pole

169

824

1.70

9.40

2.2

2.3

—

In situ neoplasms

189

1106

1.64

9.36

2.4

2.5

—

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

7.28

9.36

2.8

2.5

—

Hypoplasia of dental enamel, prenatal , including avohilmo

6.47

9.32

2.8

2.4

—

Diseases of salivary glands

120

651

1.85

9.29

2.3

2.5

—

Diseases of middle ear and mastoid

531

3259

1.34

9.24

2.5

—

Hypersplenism

17.03

9.24

2.4

—

Portal vein thrombosis

5.44

9.22

2.3

—

Postpartum hemorraghe, parous women as controls

315

1901

1.46

9.17

2.8

2.6

—

Peripheral arterial reconstruction

320

2.23

9.15

2.2

2.3

—

Dermatopolymyositis

4.91

9.13

2.3

2.5

—

Diaphragmatic hernia

177

1079

1.65

9.08

2.4

2.3

—

Chronic ulcer of skin, not elsewhere classified

159

2.80

9.07

2.4

—

Preterm labour and delivery

187

1157

1.63

9.06

2.5

—

Acute pancreatitis (for exclusion)

117

635

1.85

9.05

2.4

2.3

—

Mood [affective] disorders

806

4192

1.27

9.04

2.4

2.5

—

Tubulo-interstitial nephritis, not specified as acute or chronic

194

2.60

8.99

2.2

2.4

—

Hernia

631

3285

1.31

8.98

2.4

2.5

—

Mood disorders

806

4193

1.27

8.92

2.4

2.5

—

146

798

1.73

8.88

2.2

2.3

—

Other disorders of conjunctiva

417

2.05

8.86

2.3

2.4

—

Noninflammatory disorders of female genital tract

427

1546

1.40

8.85

2.7

2.5

—

Need for other prophylactic measures

196

2.59

8.84

2.2

2.5

—

Visual disturbances

305

2110

1.45

8.82

2.4

2.5

—

Functional dyspepsia

170

1035

1.65

8.80

2.4

2.5

—

Acquired pure red cell aplasia [erythroblastopenia]

10.61

8.73

2.2

2.7

—

Benign neoplasm: Transverse colon

246

2.38

8.65

2.2

2.3

—

Dermatopolymyositis (FG)

4.89

8.65

2.3

2.5

—

Pruritus

435

2.02

8.64

2.3

2.5

—

Hypoplasia of dental enamel, prenatal

17.63

8.63

3.1

2.4

—

Tuberculosis of other organs

4.84

8.62

2.0

2.4

—

Dental caries 3

586

2274

1.32

8.61

2.4

2.5

—

Degenerative macular diseases

216

2.47

8.61

2.1

2.3

—

Vocal cord dysfunction

434

1.98

8.61

2.3

2.6

—

Other general symptoms and signs

162

2.72

8.59

2.4

2.5

—

Elevated blood glucose level

291

2.26

8.58

2.3

2.4

—

Other disorders of glucose regulation and pancreatic internal secretion

343

2.15

8.56

2.4

—

Valvular operations

338

2.14

8.43

2.6

2.4

—

Complications following infusion, transfusion and therapeutic injection

4.77

8.41

2.7

2.6

—

Other Crohn's disease

340

2.15

8.37

2.3

2.5

—

Sickle-cell disorders

19.46

8.33

1.8

2.9

—

Benign neoplasm: Rectum, anus and anal canal

393

2.05

8.32

2.3

—

Squamous cell neoplasms and carcinomas of the skin

184

2.57

8.30

2.2

—

Dental pulpitis 2, only avohilmo

486

1849

1.35

8.26

2.4

—

Other specified/unspecified necrotizing vasculopathies

5.48

8.26

2.3

2.4

—

Disorders of optic nerve and visual pathways

436

1.99

8.25

2.3

2.5

—

conjunctival haemorrhage

191

2.54

8.24

2.2

2.4

—

Asthma-related infections

403

2914

1.36

8.20

2.4

2.5

—

Asthma, hospital admission 2, infections

403

2914

1.36

8.20

2.4

2.5

—

Late syphilis

4.68

8.19

2.4

—

External causes of morbidity and mortality

602

2315

1.31

8.18

2.5

2.6

—

5-aminosalicylic acid

165

1018

1.63

8.15

2.6

2.5

—

Artrosis, including avohilmo

352

2675

0.72

8.11

2.3

2.4

—

Benign neoplasm of other and ill-defined parts of digestive system

494

1.91

8.09

2.3

2.4

—

Recurring oral aphthae

158

2.70

8.09

2.5

—

Use of antiglaucoma preparations and miotics

152

2.72

8.08

2.3

2.4

—

Other and unspecified drugs and medicaments

306

2.18

8.03

2.1

2.4

—

Fitting and adjustment of other devices

118

619

1.78

8.00

2.3

2.4

—

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

333

2.12

7.98

2.2

2.4

—

Oxicams

909

0.52

7.98

2.3

2.5

—

Early onset COPD

132

773

1.72

7.96

2.2

2.3

—

Amyloidosis, other/unspecified

4.97

7.93

3.1

2.3

—

Other specified diseases with participation of lymphoreticular and reticulohistiocytic tissue

16.50

7.90

3.5

2.5

—

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

111

3.06

7.86

2.8

2.4

—

Exposure to unspecified factor

718

4437

1.26

7.84

2.3

2.5

—

Special screening examination for other diseases and disorders

283

2.21

7.83

2.7

2.5

—

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

383

2461

1.37

7.77

2.5

2.6

—

Carcinoma in situ of skin of scalp and neck

6.28

7.73

2.1

2.2

—

Noninfectious colitis NAS

106

589

1.81

7.70

2.3

2.5

—

Toxic liver disease

4.62

7.70

2.4

—

Inflammatory bowel disease

247

1689

1.47

7.68

2.5

—

Acquired absence of limb

6.88

7.66

2.3

2.1

—

Use of pramipexole

113

641

1.77

7.64

2.4

—

Chronic pancreatitis

366

2.04

7.61

2.3

2.4

—

Systemic lupus erythematosus, unspecified

113

2.98

7.59

2.2

2.6

—

Benign neoplasm: Ascending colon

217

2.36

7.59

2.3

—

Malignant melanoma, excluding all cancers (controls excluding all cancers)

353

2.05

7.57

2.3

—

Sequelae with surgical and medical care as external cause

112

637

1.77

7.52

2.5

2.4

—

Dermatophytosis

423

1.95

7.50

2.4

—

Kela reimbursement Agammaglobulinemia (D80-84)

5.07

7.49

3.0

2.6

—

DVT of lower extremities

543

1.83

7.49

2.5

2.4

—

Calcific aortic valvular stenosis

103

559

1.81

7.48

2.3

—

Calcific aortic valvular stenosis, operated

103

559

1.81

7.48

2.3

—

Malignant neoplasm of other and unspecified parts of biliary tract, excluding all cancers (controls excluding all cancers)

5.27

7.48

2.1

2.4

—

Operations 2 for CAVS

102

553

1.81

7.43

2.3

—

Calcific aortic valvular stenosis, diagnosis (helper)

102

553

1.81

7.43

2.3

—

Pregnancy hypertension

355

2344

1.37

7.39

2.5

2.6

—

Restrictive cardiomyopathy

17.12

7.38

3.5

1.9

—

Corns and callosities

214

2.36

7.38

2.4

—

Abnormalities of heart beat

222

1485

1.49

7.37

2.5

—

IBD patients in KELA-register

195

1284

1.53

7.33

2.5

—

COPD, hospital admission 2, with asthma infections

131

664

1.69

7.33

2.2

2.3

—

Inflammatory diseases of female pelvic organs

476

2738

1.31

7.31

2.6

2.5

—

Psychiatric diseases

846

3438

1.23

7.31

2.4

2.5

—

Calcific aortic valvular stenosis, including rheumatic fever

102

556

1.80

7.29

2.3

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

181

793

1.57

7.29

2.2

—

Obstructed labour due to malposition and malpresentation of fetus

203

1270

1.52

7.28

2.7

2.5

—

Infection due to other mycobacteria

5.50

7.28

2.4

2.3

—

Congenital malformations of the circulatory system

121

688

1.72

7.27

2.6

2.5

—

Other specified/unspecified bacterial intestinal infections

191

2.43

7.26

2.5

2.4

—

Disease of hard tissues of teeth, NOS

4.63

7.25

2.7

2.6

—

Other and unspecified immunodeficiencies with predominantly antibody defects

4.06

7.24

2.9

2.5

—

Other obstructive and reflux uropathy

174

2.51

7.19

2.3

2.5

—

Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)

180

2.46

7.15

2.2

—

Glaucoma suspect

159

1009

1.58

7.04

2.3

—

Other diseases of pancreas

194

2.39

7.03

2.4

—

Intestinal stricture

147

916

1.61

7.03

2.3

2.4

—

Cholecystitis

343

2.02

7.02

2.5

2.4

—

Scleritis

4.49

7.02

2.0

2.7

—

Sequelae of cerebrovascular disease

141

760

1.63

7.00

2.2

2.3

—

Type 2 diabetes, definitions combined

575

2687

1.28

7.00

2.3

2.5

—

Pain in throat and chest

612

2954

1.27

6.99

2.4

2.5

—

Polymyositis

6.21

6.96

2.2

2.3

—

Hyphaema and other vascular disorders of iris and ciliary body

3.77

6.96

2.5

—

Polyarteritis nodosa and related conditions

4.07

6.95

2.5

—

Carcinoma in situ of skin of trunk

4.90

6.94

2.4

2.2

—

Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)

291

2.11

6.93

2.3

—

Emphysema

165

2.51

6.92

2.2

2.3

—

Inflammatory bowel disease, strict (require KELA)

195

1302

1.51

6.90

2.5

—

Malignant neoplasm of urinary organs, excluding all cancers (controls excluding all cancers)

202

2.34

6.87

2.2

—

Neurological diseases

776

3166

1.24

6.85

2.4

2.5

—

Other diseases of intestine

340

2.01

6.83

2.4

—

COPD, hospital admissions 3, with asthma pneumonia sepsis

104

503

1.76

6.83

2.2

2.3

—

Intracerebral haemorrhage

247

2.20

6.82

2.4

2.3

—

Pneumothorax

197

2.36

6.80

2.5

2.4

—

Other noninfective disorders of lymphatic vessels and lymph nodes

3.05

6.79

2.3

2.6

—

Other diseases of jaws

255

2.18

6.76

2.5

—

Other soft tissue disorders, not elsewhere classified

728

3641

1.24

6.73

2.4

2.5

—

Xerosis cutis

4.80

6.73

2.1

2.3

—

Acute generalized exanthematous pustulosis

162

2.50

6.70

2.7

2.5

—

Ulcerative colitis

189

1264

1.50

6.65

2.5

—

Coxibs

144

1206

0.63

6.64

2.4

2.5

—

Non-allergic asthma (mode), excluding more controls

105

603

1.73

6.63

2.4

2.5

—

Parodontitis, under 40 years, or operation codes

144

910

1.60

6.62

2.4

2.7

—

Carcinoma in situ of skin

145

2.57

6.61

2.5

2.3

—

Cerebrovascular diseases

359

1913

1.35

6.58

2.4

—

Keratitis

232

1618

1.44

6.57

2.3

2.5

—

Other disorders of eye and adnexa

107

629

1.71

6.48

2.5

—

Other functional intestinal disorders

253

1709

1.41

6.47

2.4

2.5

—

Generalized skin eruption due to drugs and medicaments

153

2.52

6.47

2.7

2.5

—

Other disorders of iris and ciliary body

3.26

6.45

2.4

2.5

—

Congenital malformations of heart and great arteries

108

617

1.71

6.43

2.6

2.5

—

Hypoglycaemia, other or unspecified

274

2.10

6.41

2.4

—

Other and unspecified disorders of skin and subcutaneous tissue

197

2.31

6.36

2.5

2.4

—

Moderate visual impairment, binocular

3.62

6.33

2.2

2.6

—

Benign neoplasm: Descending colon

108

2.80

6.32

2.3

2.2

—

Other arthritis (FG)

197

1343

1.47

6.31

2.3

2.5

—

Benign neoplasm of meninges

185

2.34

6.31

2.4

—

Malignant neoplasm, without specification of site, excluding all cancers (controls excluding all cancers)

3.60

6.31

2.5

2.2

—

Benign neoplasm: Sigmoid colon

464

1.82

6.29

2.3

—

Parodontitis, operation under 40 years and operation codes

136

859

1.60

6.29

2.4

2.7

—

Other diseases of anus and rectum

151

974

1.55

6.26

2.5

—

Other puerperal infections

105

622

1.71

6.25

2.8

2.7

—

Melanocytic naevi of lower limb, including hip

156

2.47

6.21

2.9

2.5

—

Other anxiety disorders

406

2764

1.31

6.21

2.6

2.5

—

Type 2 diabetes, strict (exclude DM1)

575

2731

1.26

6.21

2.3

2.5

—

Parodontitis, under 40 years

142

909

1.58

6.20

2.4

2.7

—

Benign neoplasm: Skin of other and unspecified parts of face

325

1.98

6.20

2.5

2.4

—

Tuberculosis, IBD comorbidity

144

2.52

6.18

2.2

2.3

—

Scleritis and episcleritis

232

2.18

6.17

2.1

2.5

—

Female infertility, associated with anovulation

118

724

1.65

6.15

2.5

2.6

—

Invasive ventilation

239

2.16

6.14

2.4

2.5

—

Viral hepatitis, IBD co-morbidity

246

2.14

6.11

2.8

2.6

—

Other disorders starting during childhood or adolecense, excluding more controls

316

1.98

6.08

3.0

2.7

—

Other nutritional deficiencies

487

3757

1.27

6.06

2.4

2.5

—

Abnormality of white blood cells, not elsewhere classified

5.40

6.06

3.0

2.7

—

Any mental disorder

840

3483

1.21

6.05

2.4

2.5

—

Diseases of the ear and mastoid process

936

3963

1.20

6.05

2.5

—

Small fibre neuropathy

3.21

6.05

2.3

2.4

—

Amputation of foot

3.51

6.04

2.2

2.4

—

Intracranial and intraspinal abscess and granuloma

4.65

6.03

2.4

2.3

—

Biliary cirrhosis, NAS

16.33

6.03

2.6

2.2

—

Hypoparathyroidism

2.96

6.02

2.4

2.6

—

Complex cardiac defects

4.24

6.01

3.0

2.6

—

Constipation

511

2895

1.27

5.98

2.3

2.5

—

Lichen simplex chronicus and prurigo

190

2.29

5.97

2.5

2.4

—

Carcinoma in situ of skin of other and unspecified parts of face

106

2.75

5.95

2.3

2.2

—

Non-allergic asthma (mode)

105

623

1.68

5.94

2.4

2.5

—

Ulcerative ileocolitis

191

2.29

5.93

2.2

2.5

—

Benign neoplasm: Stomach

249

2.10

5.92

2.2

2.3

—

Fracture of foot, except ankle

184

1256

1.47

5.91

2.4

2.6

—

Other specified/unspecified arthritis

177

1199

1.48

5.89

2.3

2.5

—

Nonspecific lymphadenitis

257

2.08

5.87

2.7

2.4

—

Subjective visual disturbances

154

1015

1.52

5.86

2.4

2.5

—

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

168

766

1.51

5.85

2.3

—

Parodontitis, under 40 years and operation codes

134

859

1.58

5.85

2.5

2.7

—

Special screening examination for neoplasms

2.84

5.84

2.3

2.4

—

Diseases of tongue

173

2.33

5.84

2.5

2.4

—

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

165

752

1.52

5.83

2.3

2.2

—

Retained placenta and membranes, without haemorrhage

491

1.76

5.82

2.7

2.5

—

Paralytic ileus and intestinal obstruction

116

717

1.62

5.81

2.2

2.4

—

Chronic hepatitis NAS

4.00

5.76

2.4

2.5

—

Other epidermal thickening

138

2.49

5.72

2.2

2.5

—

Vascular disorders of the intestines

120

2.60

5.71

2.2

2.4

—

Retinal breaks without detachment

435

1.80

5.71

2.4

—

Type 2 diabetes, definitions combined, including avohilmo

579

2759

1.24

5.68

2.4

2.5

—

Misadventures to patients during surgical and medical care

480

1.76

5.67

2.5

2.4

—

Polyarteritis nodosa

6.09

5.67

2.6

2.7

—

Amyloidosis

3.76

5.67

3.1

2.2

—

Other specified/unspecified systemic involvement of connective tissue

195

2.23

5.64

2.4

2.5

—

Other benign neoplasms of skin

189

1309

1.45

5.63

2.5

2.4

—

Epilepsy

202

1413

1.43

5.62

2.4

2.5

—

Type 1 diabetes, definitions combined

104

631

1.66

5.61

2.4

2.6

—

Fentanyl

208

2.17

5.61

2.4

—

Other external causes of accidental injury

701

2881

1.22

5.59

2.4

2.5

—

Other complications of surgical and medical care, not elsewhere classified

352

1.89

5.59

2.4

—

In situ neoplasms

189

1313

1.44

5.55

2.4

2.5

—

315

2362

1.33

5.52

2.5

—

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

203

1432

1.42

5.49

2.5

—

Disorders of conjunctiva

603

4122

1.23

5.49

2.5

—

Tuberculosis, wide

160

2.33

5.42

2.2

2.3

—

Disorders of eyelid, lacrimal system and orbit

510

3210

1.25

5.41

2.4

2.5

—

Acute bronchiolitis

306

1.90

5.41

2.7

—

Diseases of the musculoskeletal system and connective tissue

547

2203

1.25

5.39

2.4

2.6

—

Crohn disease

113

710

1.60

5.37

2.4

2.5

—

Macular pucker

274

1.98

5.29

2.1

2.3

—

Kela-code for severe mental illness

140

2081

0.67

5.28

2.2

2.5

—

Cryoglobulinemia

15.23

5.25

2.5

3.0

—

Cystic fibrosis, other manifestations/unspecified

15.16

5.24

2.3

3.2

—

Drug-induced hypoglycaemia without coma

3.71

5.23

2.3

2.6

—

Benign neoplasm: Colon, unspecified

102

630

1.63

5.19

2.3

—

Cystic fibrosis

14.49

5.19

2.3

3.2

—

Open wound of lower leg

577

1.66

5.18

2.5

—

Type 1 diabetes, strict (exclude DM2)

103

638

1.62

5.16

2.4

2.6

—

Allergic bronchopulmonary aspergillosis (ABPA)

14.08

5.15

2.5

2.3

—

Benign neoplasm of major salivary glands

230

2.06

5.11

2.2

2.3

—

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

373

1.82

5.10

2.9

2.6

—

Abnormal findings in nipple discharge synovial fluid wound secretions

3.24

5.08

2.4

2.6

—

Postzoster neuralgia

4.53

5.06

2.0

2.4

—

378

2719

1.28

5.06

2.3

2.5

—

Myocardial infarction

223

1156

1.39

5.05

2.2

2.4

—

Other neurological diseases

367

2300

1.29

5.02

2.4

—

Benign neoplasm: Cerebral meninges

166

2.24

5.00

2.5

2.4

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

344

2618

1.29

4.95

2.4

—

Obesity due to excess calories

342

2659

1.29

4.94

2.3

2.5

—

Hypothyroidism, strict autoimmune

505

2705

1.24

4.91

2.4

2.5

—

Hyperhidrosis

112

2.53

4.90

2.4

2.6

—

Other and unspecified glaucoma

130

2.40

4.89

2.3

2.4

—

Nonalcoholic steatohepatitis

4.44

4.88

2.3

2.6

—

Other disorders starting during childhood or adolescence

352

1.83

4.87

3.0

2.7

—

Urticaria and erythema

261

1960

1.34

4.86

2.5

—

Spondylopathies in diseases classified elsewhere

4.38

4.85

3.4

2.5

—

Undetermined asthma, excluding more controls

376

1.79

4.85

2.4

2.6

—

Alcohol use disorder, Swedish definition

349

2532

1.28

4.79

2.3

2.5

—

Other systemic involvement of connective tissue (FG)

136

908

1.49

4.79

2.3

2.5

—

Convalescence

144

2.31

4.78

2.8

2.5

—

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

2.85

4.76

2.2

2.7

—

Benign neoplasm: Caecum

170

2.19

4.74

2.1

2.3

—

Obesity

452

3616

1.24

4.73

2.3

2.5

—

Other arrhythmias

378

2282

1.27

4.71

2.4

2.5

—

Alport

11.68

4.71

2.0

3.6

—

Ventral hernia

113

733

1.55

4.71

2.3

2.4

—

Pain in limb

567

3379

1.22

4.70

2.4

2.5

—

Obesity and other hyperalimentation

453

3626

1.24

4.69

2.3

2.5

—

Cyst of kidney

158

2.23

4.69

2.1

2.3

—

Melanocytic naevi of lower limb, including hip

178

2.16

4.68

2.9

2.5

—

Obesity related asthma

194

1400

1.39

4.68

2.3

2.4

—

Other aneurysm

121

2.42

4.64

2.6

2.4

—

Malignant cancer of tonsil and base of tongue, excluding all cancers (controls excluding all cancers)

3.25

4.63

2.1

2.2

—

Other proliferative retinopathy

8.61

4.63

2.2

2.8

—

Benign neoplasm: Duodenum

3.53

4.63

2.3

—

Malignant neoplasm of head and neck, excluding all cancers (controls excluding all cancers)

205

2.06

4.62

2.2

2.3

—

Undetermined asthma

382

1.76

4.62

2.4

2.6

—

Juvenile Open Angle Glaucoma

4.58

4.62

2.4

2.7

—

Maternal care for cervical incompetence

166

2.20

4.61

2.9

2.5

—

Lung diseases due to external agents

346

1.80

4.60

2.3

—

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

497

1.66

4.58

2.5

2.6

—

Open wound of ankle and foot

459

1.69

4.57

2.2

2.5

—

Status epilepticus

116

2.44

4.57

2.5

—

Finngen Rheumatological endpoints

749

3608

1.19

4.57

2.3

2.5

—

Major coronary heart disease event

322

1663

1.29

4.56

2.2

2.3

—

Infarction of spleen

10.37

4.56

2.3

2.6

—

Benign neoplasm: Parotid gland

193

2.09

4.55

2.2

2.3

—

Schizophrenia

822

0.52

4.53

2.3

2.4

—

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

402

1.73

4.47

2.4

2.6

—

Other and unspecified follicular disorders

169

2.16

4.43

2.1

2.5

—

Other endophthalmitis

7.83

4.41

2.0

3.0

—

Hydrocele

344

1.78

4.40

2.3

—

Essential (haemorrhagic) thrombocythaemia

2.84

4.40

2.3

2.4

—

Other diseases of gallbladder

106

2.48

4.39

1.9

2.5

—

Supplementary factors related to causes of morbidity and mortality classified elsewhere

200

1468

1.37

4.38

2.5

—

Lack of expected normal physiological development

102

2.43

4.38

3.3

2.7

—

Other disorders of breast and lactation associated with childbirth

138

2.31

4.38

3.1

2.7

—

Ocular pain

345

1.78

4.38

2.3

2.5

—

Disorders of globe

3.13

4.38

2.1

2.4

—

Cytomegaloviral hepatitis

9.58

4.37

2.0

2.6

—

394

2832

1.25

4.36

2.3

2.5

—

Adverse effects, not elsewhere classified

149

1042

1.44

4.35

2.4

2.6

—

Schizophrenia, schizotypal and delusional disorders

121

1774

0.68

4.34

2.4

2.5

—

Other retinal artery occlusion

3.54

4.34

2.5

2.4

—

Monocytic leukaemia

12.33

4.33

4.3

2.3

—

Twin gestation

451

1.68

4.33

2.5

—

Bacterial, viral and other infectious agents

436

1.69

4.33

2.5

2.4

—

Brain meningioma, excluding all cancers (controls excluding all cancers)

2.55

4.30

2.5

2.4

—

Prurigo nodularis

2.99

4.30

2.1

2.4

—

Systemic sclerosis

2.99

4.30

2.7

—

Nail disorders

347

1.77

4.30

2.2

2.4

—

Oter anti-inflammatory and antirheumatic agents, non-steroids

646

0.60

4.30

2.2

2.4

—

Type of accident

181

1312

1.38

4.29

2.5

—

Giant cell arteritis

2.80

4.29

2.3

—

Schizophrenia or delusion

121

1769

0.68

4.29

2.4

2.5

—

Other meningitis

3.09

4.26

2.5

2.6

—

Pre-eclampsia or eclampsia

162

1155

1.41

4.25

2.5

2.6

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Toxoplasma gondii IgG Ab [Units/volume] in Serum

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS